Chart, page-5635

I hope so Sam. Anp are creating a truck load of data showing the interaction of ATL1102 with a number of inflammation specific bio markers.

Other independent research has tied some of those bio markers to long covid. Can big pharma be challenged to treat the inflammation instead of symptoms? And if they do, and it works, imagine the cascade into other related bio marker indications.

Lots of potential.

I am not sure if it was posted on the ANP threads a while ago or I saw it somewhere else, but there is an excellent lecture from Dublin's Trinity college by an Irish researcher into inflammation on YouTube. He explains his hypothesis of how over expression of somd Cd protein related inflammation is basically the root cause of most human chemical imbalance problems. leading to everything from cancer to MS and lots in-between. He argues that it is the rouge inflammation that prevents the body from healing itself, or in some indications, leads the immune system to over react and cause harm.

The phase 2 DMD data supports this. Hopefully the long covid data does as well.